Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
In need of quick funds? Discover ways to get cash instantly from bank services to meet your urgent needs.
21,071 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Microsoft marks 40 years since its 1986 IPO, a milestone that underscores the power of long-term investing. The anniv...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Palantir often looks pricey at first glance, but the real story may be hidden in growth engines and future contracts....
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Unlock sharper insights with the best websites for financial analysis. This guide compares top platforms, from screen...
Insider buying can hint at confidence from leadership, but it isn’t a crystal ball. This guide explains how to interp...
A late-night incident went viral for all the wrong reasons, and the real price wasn’t just fear or headlines. This pi...
Apple secured a commanding lead in the 2026 chip race by locking more than half of TSMC's 2nm capacity, while Google ...
AMD’s latest earnings reinforce its role in the AI infrastructure wave, setting up this stock biggest bet for May as ...
A controversial post and a geopolitical rumor collide with everyday money concerns. This article shows how to transla...